ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,000 | -28.1% | 24,358 | +3.2% | 0.00% | – |
| Q2 2023 | $32,000 | -97.4% | 23,593 | -28.0% | 0.00% | -100.0% |
| Q3 2020 | $1,217,000 | +12.8% | 32,753 | +51.9% | 0.01% | 0.0% |
| Q2 2020 | $1,079,000 | +58.7% | 21,568 | -10.1% | 0.01% | +50.0% |
| Q1 2020 | $680,000 | -50.9% | 23,993 | -2.7% | 0.00% | -50.0% |
| Q4 2019 | $1,386,000 | +80.2% | 24,668 | +9.4% | 0.01% | +100.0% |
| Q3 2019 | $769,000 | -41.0% | 22,549 | -19.8% | 0.00% | -50.0% |
| Q2 2019 | $1,304,000 | +69.4% | 28,115 | +46.5% | 0.01% | +60.0% |
| Q1 2019 | $770,000 | -6.7% | 19,189 | +6.8% | 0.01% | -16.7% |
| Q4 2018 | $825,000 | +6.0% | 17,961 | +2.3% | 0.01% | 0.0% |
| Q3 2018 | $778,000 | – | 17,550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $99,609,000 | 22.32% |
| Bellevue Group AG | 5,465,715 | $203,160,000 | 2.81% |
| Rhenman & Partners Asset Management AB | 455,000 | $16,912,000 | 1.50% |
| Endurant Capital Management LP | 135,901 | $5,051,000 | 1.49% |
| Boxer Capital, LLC | 975,000 | $36,241,000 | 1.25% |
| DCF Advisers, LLC | 56,500 | $2,100,000 | 1.07% |
| Pentwater Capital Management LP | 2,169,022 | $80,623,000 | 1.04% |
| Nicholas Investment Partners, LP | 235,855 | $8,767,000 | 0.95% |
| Amia Capital LLP | 20,464 | $761,000 | 0.88% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,717,000 | 0.83% |